Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mehy.2020.109802 http://scihub22266oqcxt.onion/10.1016/j.mehy.2020.109802 32526507!7239001!32526507     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32526507&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Med+Hypotheses 2020 ; 144 (ä): 109802 Nephropedia Template TP {{tp|p=32526507|t=2020. Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19 |pdf=|usr=}}{{32526507}} gab.com Text Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19 JO: Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=32526507 #FOAvip The ongoing pandemic of COVID-19 infection demands efforts to reduce spread. In order to eradicate an infectious disease, a method of prevention with low social cost is the most effective way. While we wait for new therapies and a vaccine, we are proposing a solution based on the existing knowledge in biomedical sciences. Here we propose to use low doses of hydroxychloroquine (50-100 mg daily orally) and intranasal interferon alpha-2b (IFN alpha-2b) spray (0.5 x 10(6) IU twice daily) for the prophylaxis of COVID-19. Although there are ongoing clinical trials to test the efficacy of hydroxychloroquine for prophylaxis, there has not been any proposal to test the efficacy of IFN alpha-2b together with hydroxychloroquine to increase protection against COVID-19. Since the two act on two different mechanisms, we strongly believe that the two could have additive effects in prophylaxis against COVID-19. We recommend using a randomized control study to prove efficacy and safety. Twit Text FOAVip Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19 ????Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=32526507 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32526507 #FOAvip English Wikipedia <ref>{{Cite pmid|32526507}}</ref> Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19 #MMPMID32526507 Yang A; Yang C; Yang B Med Hypotheses 2020[Nov]; 144 (ä): 109802 PMID32526507show ga The ongoing pandemic of COVID-19 infection demands efforts to reduce spread. In order to eradicate an infectious disease, a method of prevention with low social cost is the most effective way. While we wait for new therapies and a vaccine, we are proposing a solution based on the existing knowledge in biomedical sciences. Here we propose to use low doses of hydroxychloroquine (50-100 mg daily orally) and intranasal interferon alpha-2b (IFN alpha-2b) spray (0.5 x 10(6) IU twice daily) for the prophylaxis of COVID-19. Although there are ongoing clinical trials to test the efficacy of hydroxychloroquine for prophylaxis, there has not been any proposal to test the efficacy of IFN alpha-2b together with hydroxychloroquine to increase protection against COVID-19. Since the two act on two different mechanisms, we strongly believe that the two could have additive effects in prophylaxis against COVID-19. We recommend using a randomized control study to prove efficacy and safety. |Antiviral Agents/therapeutic use[MESH] |COVID-19/*prevention & control[MESH] |Drug Administration Schedule[MESH] |Drug Therapy, Combination[MESH] |Humans[MESH] |Hydroxychloroquine/*therapeutic use[MESH] |Interferon alpha-2/*therapeutic use[MESH] |Models, Theoretical[MESH] |Randomized Controlled Trials as Topic[MESH] |Recombinant Proteins/therapeutic use[MESH]Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis (epmc).pdf DeepDyve Pubget Overpricing